Related Experiment Videos
[Comparative morphologic characteristics of viral hepatitis B and C]
Arkhiv Patologii
|September 1, 1996
Summary
This study differentiates chronic hepatitis B (HBV) and hepatitis C (HCV) infections using liver biopsy markers. Specific histological features help identify HBV, HCV, or co-infections, indicating the dominant replicating virus.
Area of Science:
- Hepatology
- Virology
- Pathology
Background:
- Chronic hepatitis B (HBV) and hepatitis C (HCV) are significant global health concerns.
- Distinguishing between HBV and HCV infections, especially in co-infections, is crucial for effective management.
- Liver biopsy analysis provides essential morphological insights into viral hepatitis pathogenesis.
Purpose of the Study:
- To identify and compare distinct morphological differences in liver biopsies between chronic HBV and HCV infections.
- To elucidate the significance of specific histological markers in diagnosing HBV, HCV, and HBV/HCV co-infections.
- To determine etiological markers indicative of the predominant replicating virus in co-infections.
Main Methods:
- Analysis of liver biopsies from patients with chronic HBV, chronic HCV, and HBV/HCV co-infections.
- Histopathological examination to identify and quantify specific cellular and tissue alterations.
- Correlation of morphological findings with etiological viral markers.
Main Results:
- Nonspecific morphological markers were observed in both HBV and HCV infections.
- Hepatitis C was associated with fat and hydropic hepatocyte degeneration, lymphoid follicles, sinusoidal changes, and ductular alterations.
- Hepatitis B was characterized by ground-glass hepatocytes and "sand" nuclei.
- Combinations of these markers were characteristic of HBV/HCV co-infections, reflecting the predominant replicating virus.
Conclusions:
- Distinct histopathological features can differentiate between chronic HBV and HCV infections.
- Specific morphological markers are valuable for diagnosing HBV, HCV, and their co-infections.
- Liver biopsy analysis aids in identifying the dominant viral activity in cases of HBV/HCV co-infection.